Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03038399
Recruitment Status : Enrolling by invitation
First Posted : January 31, 2017
Last Update Posted : August 28, 2018
Sponsor:
Collaborators:
University of Pittsburgh
Cooperative International Neuromuscular Research Group
Information provided by (Responsible Party):
ReveraGen BioPharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : January 2021
  Estimated Study Completion Date : January 2021